European Med-Biotech Accelerator

Over the last decade, the EU’s medical technology and biotechnology sectors have been major drivers of economic transformation. In 2024, the EU Medtech industry reached a turnover of EUR 170 billion, employed over 900,000 people, and grew by 60% since 2014, with significant productivity gains. During the same period, the EU biotech industry has grown more than twice as fast as the overall EU economy and is one of the most productive industries. However, although medical technology and biotechnology respectively recorded 15,701 and 8,479 patent applications at the European Patent Office in 2025, the EU continues to face challenges in translating Medtech and Biotech innovation into market-ready products and in effectively pooling expertise and infrastructures.

This CCT Med-Biotech Pilot is a 4-year project leveraging the combined potential of Medtech and Biotech innovation to bring groundbreaking health solutions to European patients. During its first phase, it will connect existing Medtech and Biotech infrastructures with complementary expertise – including biotech clusters and hubs, Medtech SMEs, pre-clinical and translational research institutions. Then, the project will support and validate two Med-Biotech product development projects – e.g. in the field of oncology and cardiovascular diseases – from late-stage research to industrial validation. The project will eventually facilitate the scale-up of the project outcomes through the commercialisation and investment strategies and clinical readiness.